CBR International has been acquired by Novotech,
the leading Asia Pacific centered biotech CRO,
to expand drug development and FDA regulatory expertise
Dr. Michael Strauss featured in CBSA panel discussion on opportunities and challenges in the cell and gene therapy sector
Dr. Babaji Yadav featured in panel discussion webinar on global vaccine development landscape
Dr. Jeanne Novak featured in panel discussion webinar on global biotech landscape
Read about this and more company news
Industry News Highlights:
FDA grants Accelerated Approval to Leqembi for treatment of Alzheimer’s disease
FDA Clinical Investigator Training Course (CITC) 2022 (available online)
FDA authorizes updated (bivalent) COVID-19 vaccines for children down to 6 months of age
FDA's Coronavirus Treatment Acceleration Program (CTAP):
We are currently assisting clients with COVID-19 development programs and we are very familiar
with the Coronavirus Treatment Acceleration Program (CTAP).
Please contact us
if you need assistance or general advice related to this.
Regulatory Submissions in eCTD and Alternate Electronic Formats:
We are up-to-date on all FDA electronic submissions requirements!
Visit our Services page
or contact us
Read about these and more industry news highlights